NEXT Normal is the ultimate event for CX, commercial excellence, marketing, and medical affairs leaders who want to design better engagement outcomes with HCPs and other stakeholders.
Speakers on this panel include masterminds from pharmaceuticals, digital health companies and tech companies. This includes Orchid Jahanshahi, Vice President of Lifescience at ODAIA and Jérôme de Larosière, Head of Marketing, Rare Diseases at IPSEN. An invitation for the registration can be found here.
Date: Tuesday, September 21, 2021
Time: 4:00 to 4:30 CET
Attendees: +1000 attendees
Panelists: +50 thought leaders in pharma marketing and sales
ODAIA has innovated the first AI-powered Customer Data Platform (CDP) that pioneered the combination of process mining, customer journey mapping and AI to deliver goal-driven commercial insights and process automation as a SaaS.
ODAIA offers a self-serve platform: MAPTUAL, serving the biopharma industry.
Pharma's Customer-Facing Teams are Transforming to Digital
The global pandemic has changed the customer-facing pharma business, forever. With direct access more difficult than ever, and HCP preferences shifting permanently toward digital engagement and personalized support, digital transformation is now a main priority.
Ready to Leap Forward with the Power of AI and Predictive Analytics?
ODAIA’s Trend Report highlights the key trends facing Pharma today to embrace AI.
Integrate all of your sales and marketing touchpoints, customer Rx and behavioral data, together with other data sets into a single platform. Spend less time looking at static dashboards and spreadsheets, and more time engaging your customers.